Vox Markets Logo
12th October 2018
06:00

AIM - Cancellation - Abzena Plc

11th October 2018
06:44

Abzena PLC - Scheme of Arrangement becomes Effective

11th October 2018
06:30

AIM - Suspension - Abzena Plc

10th October 2018
13:42

Abzena PLC - Court sanction of the scheme of arrangement

10th October 2018
13:40

Abzena PLC - Exercise of options

4th October 2018
16:30

FTSE - Abzena

2nd October 2018
12:51

Abzena PLC - Results of Court Meeting and General Meeting

19th September 2018
08:01

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company

19th September 2018
08:01

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company

17th September 2018
11:55

Abzena PLC - Result of Annual General Meeting

10th September 2018
12:35

Abzena PLC - Posting of Scheme Document

5th September 2018
16:16

Abzena PLC - Form 8.3 - Abzena Plc

31st August 2018
12:45

The Wellcome Trust - Form 8.3 - Abzena Plc

30th August 2018
17:28

Abzena PLC - Change of Adviser

24th August 2018
11:03

Nplus1 SingerCapital - Form 8.5 (EPT/RI) ABZENA Plc

23rd August 2018
16:41

Abzena PLC - Form 8 (OPD) - Abzena Plc

23rd August 2018
15:48

Abzena PLC - Notice of AGM

23rd August 2018
08:14

Nplus1 SingerCapital - Form 8.5 (EPT/RI) Abzena Plc

22nd August 2018
17:09

Abzena PLC - Form 8.3 - Abzena Plc

21st August 2018
11:00

Peel Hunt LLP - Form 8.5 (EPT/RI) - Abzena Plc

Abzena Plc (ABZA.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    213.64M

Abzena Plc Company Profile

Abzena is a life sciences group with its headquarters in the UK and two sites in the US. Abzena offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals, products based on antibodies or other proteins.

Watchlist